Theranos

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Still Going for Small

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

The US Securities and Exchange Commission charged Elizabeth Holmes, the founder and CEO of Theranos, with fraud.

The Wall Street Journal reports that the erstwhile partners have reached a settlement of more than $25 million.

Asking for the Data

Biotech investors are learning from their mistakes following the Theranos fiasco, according to Wired.

Theranos Settles

The embattled firm has reached deals with both the Centers for Medicare & Medicaid Services and Arizona.

Elizabeth Holmes, the founder of Theranos, owes the firm millions, the Wall Street Journal reports.

'Repeated Violations'

A federal inspection report obtained by the Wall Street Journal describes deficiencies at Theranos' Arizona lab.

Second Failure

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

Pages

York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.

In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.

The Scientist reports agricultural researchers are working on a gene-stacking tool.

In Nature this week: statistical method for overcoming case-control imbalance issues, and more.